Cargando…
Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya
INTRODUCTION: From the first case of SARS-Co-2 in Wuhan, China, to the virus being declared as a pandemic in March 2020, the world has witnessed morbidity and mortality on a global scale. Scientists have worked at a record pace to deliver a vaccine for the prevention of this deadly disease. Tocilizu...
Autores principales: | Shah, Reena, Shah, Jasmit, Gohil, Jaimini, Revathi, Gunturu, Surani, Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901262/ https://www.ncbi.nlm.nih.gov/pubmed/35264878 http://dx.doi.org/10.2147/IJGM.S356547 |
Ejemplares similares
-
TOCILIZUMAB IN COVID-19: EAST-AFRICAN EXPERIENCE
por: SHAH, R., et al.
Publicado: (2022) -
Demographic, Clinical, and Co-Morbidity Characteristics of COVID-19 Patients: A Retrospective Cohort from a Tertiary Hospital in Kenya
por: Shah, Reena, et al.
Publicado: (2022) -
Tocilizumab: Secondary organising pneumonia: case report
Publicado: (2022) -
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
por: Salama, Carlos, et al.
Publicado: (2020) -
553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)